CD44 and neoplasm: Similarly, following the inoculation of pure mCherry-expressing CD44+/CD24low/− cells to mice, the tumors consisted of 52 ± 6.9% mCherry-expressing cells but only 4.5 ± 1.1% of the mCherry-expressing tumor cells retained the CD44+/CD24low/− phenotype (Table 1B).